Hematology/Medical Oncology Fellowship Program Overview
The Division of Hematology/Oncology offers a three-year combined Hematology and Medical Oncology (Hem/Onc) training program. Trainees must complete the American Board of Internal Medicine requirements for specialty training in Internal Medicine before they will be allowed to begin subspecialty training in Hem/Onc. A trainee must be board certified in Internal Medicine AND complete training in Hem/Onc before they will be eligible for certification by the American Board of Internal Medicine in the subspecialties of Hematology and Medical Oncology. The University of Virginia Health System is a referral center providing primary and tertiary care for large portions of Virginia and West Virginia . All inpatient and outpatient services in Hem/Onc are provided in Charlottesville . The Hem/Onc inpatient service consists of 17 ward beds and 8 acute Stem Cell Transplant beds. Two attendings, one hematology and one oncology, are assigned to the inpatient service. The attendings direct a fellow, residents, interns, and medical students and provide primary coverage for the ward service. Outpatient facilities include the Stem Cell Transplant clinic, Cancer Center clinics and Infusion Center , a multi-headed microscope room for review of pathology and bone marrow specimens, and conference rooms. The University of Virginia is the recipient of a NCI Cancer Center Support Grant with basic research programs in: cell-signaling; endocrinology and cancer; immunology of cancer; metastases, invasion and cell surfaces; and clinical research focusing on drug discovery, including phase I and II clinical trials and phase III trials in cooperation with the ECOG, GOG and NSABP. To learn more please visit the Cancer Center's Research Programs page. Clinical ExperienceA fellow in the combined Hematology / Oncology training program is required by The American Board of Internal Medicine to complete 18 months of full time clinical training with patient care responsibility and 36 months of training at an outpatient continuity clinic. Full time clinical training is defined as at least 80% of the fellow’s professional time during a working week dedicated to clinical (patient care or educational) activities. The 18 months of clinical activity must include 6 months of benign hematology and 12 months of neoplastic diseases including malignant hematology. In addition, the board requires training in a number of associated disciplines and procedures. These requirements are met by rotations on the ward service, hematology consult service, the oncology consult service and selected clinical electives.
ResearchParticipation in a research project during the fellowship is required. A fellow must chose a basic or clinical research track before the end of the first year of fellowship. The design of the last two years of training differs depending on whether a fellow elects the basic or clinical research track. The basic research track requires completion of all but the continuity clinic portion of the clinical requirements by the end of the second year so that a full year may be spent in the research laboratory with few interruptions for clinical service. Fewer electives are available as the basic research fellow concentrates on the core clinical components only to allow additional time in the research laboratory. Several basic research areas are available through the Cancer Center. The clinical research track begins at the end of the first year. Clinical research requires continued involvement of the fellow for at least two full years although only isolated months will be reserved for research-only activities. Patient accrual into trials and intermittent study activity occur continuously and therefore fellows will frequently be participating simultaneously in research activities and other clinical rotations. Clinical research protocols are available within the context of ECOG and other collaborative groups and as investigator-generated protocols in cancer and hemostasis. TeachingDidactic lectures are an on going part of the fellowship and there are a number of conferences available to enhance this aspect of the fellowship. For the first 2 months of each year a series of lectures is given three times per week and covers a broad range of topics in Hematology and Oncology. Conferences including Grand Rounds/Cancer Center Seminars, journal club, bone marrow sign-out, and tumor boards occur several times a week. Fellows are required to teach residents and medical students on rotations and over the course of the 3 years the fellow prepares several grand rounds presentations, journal clubs and various posters and talks for presentation at local and national meetings. A board review lecture series designed and implemented by the fellows is provides an opportunity to teach peers and concentrate on specific topics over the three-year fellowship. |